Pharmaceuticals

Global Budesonide Market 2025–2029: Competitive Insights and Opportunities

November 10, 2025 by Marketing Posting

Unlock Global Insights – Save 20% on Market Reports with Code ONLINE20

What Is The Expected Total Market Size Of The Budesonide Industry By The Forecast Year 2029?

The budesonide market has experienced substantial growth in recent years. It is anticipated to expand from $9.72 billion in 2024 to $10.26 billion in 2025, exhibiting a compound annual growth rate (CAGR) of 5.6%. This historical growth can be linked to several factors including the rising prevalence of respiratory diseases, greater awareness of inhaled corticosteroids, the introduction of budesonide-based combination therapies, the expansion of healthcare access and infrastructure, and the adoption of budesonide for off-label applications in inflammatory bowel diseases.

The budesonide market is poised for significant expansion in the coming years. It is projected to reach $12.95 billion by 2029, demonstrating a compound annual growth rate (CAGR) of 6.0%. This growth during the forecast period is attributed to several factors, including the increasing demand for effective treatments, the development of novel drug delivery systems, the expanding use of budesonide, a rising geriatric population susceptible to asthma, and the proliferation of generic budesonide products. Key trends anticipated in this period encompass the adoption of biologics and biosimilars, ongoing advancements in drug delivery systems, regulatory approvals for new formulations, and broader technological development.

Unlock Your Free Sample Report for Exclusive Market Data:

https://www.thebusinessresearchcompany.com/sample.aspx?id=21121&type=smp

What Are The Emerging Market Drivers Creating New Opportunities In The Budesonide Industry?

The rising occurrence of respiratory conditions is anticipated to propel the growth of the budesonide market moving forward. Respiratory diseases are defined as medical conditions that affect the organs and tissues responsible for regulating gas exchange in air-breathing animals. This increase in the prevalence of respiratory diseases stems from escalating air pollution, particularly exposure to particulate matter and allergens, which significantly impacts the prevalence of asthma and chronic obstructive lung disease. Budesonide is utilized in the treatment of respiratory diseases such as asthma and chronic obstructive pulmonary disease (COPD) to reduce inflammation, improve airflow, and prevent symptoms like wheezing and shortness of breath. For instance, in May 2024, according to the National Center for Health Statistics (NCHS), a US-based health statistics agency, the prevalence of current asthma among adults aged 18 and over in the United States increased from 8.4% in 2021 to 8.7% in 2022. Additionally, the incidence of asthma episodes in the past 12 months for adults in the same age group rose from 3.3% in 2021 to 3.7% in 2022. Therefore, the growing prevalence of respiratory diseases will drive the expansion of the budesonide market.

How Is The Budesonide Market Segmented?

The budesonide market covered in this report is segmented –

1) By Type: Inhalation Powder, Aerosols, Injectable Suspension, Tablets And Capsules

2) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies

3) By Application: Nose Disease Treatment, Inflammatory Bowel Disease Treatment, Respiratory Disease Treatment, Other Applications

Subsegments:

1) By Inhalation Powder: Dry Powder Inhalers (DPI), Soft Mist Inhalers (SMI)

2) By Aerosols: Metered-Dose Inhalers (MDI), Breath-Activated Inhalers

3) By Injectable Suspension: Pre-filled Syringes, Vials

4) By Tablets And Capsules: Oral Tablets, Oral Capsules

How Are Trends Influencing The Budesonide Market?

Key companies within the budesonide market are directing their efforts towards breakthroughs in respiratory treatment, including oral therapy, aiming to boost patient comfort, ensure better treatment adherence, and widen the range of therapeutic choices for managing asthma and other respiratory issues. Oral therapy budesonide is a version of budesonide administered by mouth, primarily employed in treating inflammatory conditions. As an illustration, in February 2024, Takeda Pharmaceuticals, a pharmaceutical firm from Japan, declared that the Food and Drug Administration (FDA), a US federal body, had given its approval to EOHILIA, an oral suspension of budesonide, making it the first and sole FDA-cleared oral medicine for individuals aged 11 and above afflicted with eosinophilic esophagitis (EoE). Additionally, the FDA authorized EOHILIA 2 mg twice daily, basing its decision on efficacy and safety information gathered from two 12-week multicenter, randomized, double-blind, parallel-group, placebo-controlled studies conducted on participants aged 11 to 56 with EoE.

Which Key Players Are Driving Competition In The Budesonide Market?

Major companies operating in the budesonide market are AstraZeneca AB, Novartis AG, Takeda Pharmaceuticals Company Limited, Viatris Inc., Teva Pharmaceutical Industries Ltd., Sandoz AG, Aurobindo Pharma Limited, Chiesi Farmaceutici S.p.A., Cipla Limited, Lupin Limited, Orion Corporation, Salix Pharmaceuticals Inc., Synmosa Biopharma Corporation, Cosmo Pharmaceuticals N.V., Skyepharma Holdings Inc., Manus Aktteva Biopharma LLP, Cennet Biopharma Private Limited, Santarus Inc., SiNi Pharma Private Limited, Shanghai Sine Promod Pharmaceutical Co. Ltd.

Download The Full Report For Exclusive Market Findings:

https://www.thebusinessresearchcompany.com/report/budesonide-global-market-report

Which Geographies Are Emerging As Strong Markets For The Budesonide Industry?

North America was the largest region in the budesonide market in 2024. The regions covered in the budesonide market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Version Of The Budesonide Market Report:

https://www.thebusinessresearchcompany.com/customise?id=21121&type=smp

Browse Through More Reports Similar to the Global Budesonide Market 2025, By The Business Research Company

Corticosteroid Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/corticosteroid-global-market-report

Inflammatory Bowel Disease Treatment Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/inflammatory-bowel-disease-treatment-global-market-report

Non Steroidal Anti Inflammatory Drugs Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/non-steroidal-anti-inflammatory-drugs-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795